Bupa today announces the appointment of Paul Evans, Nicholas Lyons and Matías Rodríguez Inciarte to its Board as Non-Executive Directors.
This follows Roger Davis’ appointment as Chairman from 1 January 2019 when Lord Leitch steps down at the end of the year and the retirement of Lawrence Churchill CBE in May 2018. Simon Blair will step down from the Bupa Board at the end of his current term on 11 January 2019 and will become Chairman of the Bupa Chile subsidiary Board from January 2019. Caroline Silver was appointed Chair of the Bupa Board’s Risk Committee from 3 October, replacing Simon Blair who remains a member of the Committee until his departure.
Paul Evans and Nicholas Lyons will join the Bupa Board on 1 November 2018, with the appointment of Matías Rodríguez Inciarte effective from 1 January 2019.
Paul Evans has a distinguished executive career in insurance, and currently acts as an advisor to two fintech businesses. He is a chartered accountant and spent 13 years with PricewaterhouseCoopers before joining AXA in 2000. He held a number of senior roles at AXA including Chief Financial Officer of AXA UK, CEO of AXA Life, Group CEO AXA UK, and Group CEO of AXA Global Life, Savings and Health. Paul is a former Chairman of the Association of British Insurers.
Nicholas Lyons has board experience with a number of insurance organisations, and is Chairman of Clipstone Logistics REIT plc. He has held a number of non-executive roles including Chairman of Miller Insurance Services LLP, Senior Independent Director of the Pension Insurance Corporation plc and Catlin Group Limited, and a Non-Executive Director of Friends Life Group Limited and Friends Life Holdings plc. Prior to this he held senior executive roles at JP Morgan and Lehman Brothers.
Matías Rodríguez Inciarte is a Non-Executive Director of Sanitas, S.A. de Seguros, Bupa’s Spanish health insurance business, Chairman of Unión de Créditos Inmobiliarios, S.A., E.F.C., and a Non-Executive Director of Financiera El Corte Inglés E.F.C., S.A, both credit institutions. He is also an Independent Director of Financiera Ponferrada S.A. Sicav, a Spanish investment fund. Prior to this he held a number of executive roles at Banco Santander S.A., in the Spanish civil service and as a Minister in the Spanish Government.
Caroline Silver is a Managing Director at Moelis & Company, Non-Executive Chairman of FMCG Group PZ Cussons plc, and a Trustee of the Victoria & Albert Museum. A qualified Chartered Accountant, Caroline was previously Vice Chairman of EMEA Investment Banking at Bank of America Merrill Lynch and spent 14 years at Morgan Stanley, where she held a number of senior positions including Global Vice Chairman of Investment Banking and European Head of Financial Institutions.
Lord Leitch, Chairman of Bupa, said: “We are delighted to welcome Paul, Nicholas and Matías to the Board. Paul and Nicholas both bring extensive experience of the UK financial services sector. Matías brings knowledge of Spanish financial services, risk management and understanding of our Spanish health insurance business. We look forward to benefiting from their experience as we focus on delivering for our customers and driving strong and sustainable growth.
“I would like to thank Simon for his valuable contribution to the Board over the past three years. As Chair of the Risk Committee he has overseen further strengthening of Bupa’s governance of this critical agenda. I know that he will make an excellent Chairman of the Bupa Chile subsidiary Board”.
“I am delighted that Caroline is now Chair of this Committee. Caroline joined the Board of Bupa in November 2017 and is also a member of the Audit Committee. Caroline has 30 years of experience in international investment banking as well as extensive experience in advising clients, and of regulators across Europe.”
Notes to editor
For more information please contact:
Media
Helen Vaughan-Jones, Mar Soro (Corporate Affairs): +44 (0)2033 141122 / +44 (0)7860 735902
Investors
Gareth Evans (Treasury): +44 (0) 20 3314 1708
About Bupa
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world.
We are an international healthcare company serving over 31 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.
We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Turkey, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.